These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
762 related articles for article (PubMed ID: 9251595)
1. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results. Mane I; Cartel JL; Grosset JH Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595 [TBL] [Abstract][Full Text] [Related]
2. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy. Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion. Majumder V; Saha B; Hajra SK; Biswas SK; Saha K Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091 [TBL] [Abstract][Full Text] [Related]
4. Single-dose treatment for paucibacillary leprosy; clinical problems and management. Pai VV; Bulchand HO; Revankar CR; Ganapati R Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414 [No Abstract] [Full Text] [Related]
5. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin. Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382 [TBL] [Abstract][Full Text] [Related]
6. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up. Ganapati R; Revankar CR; Pai VV; Kingsley S Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413 [No Abstract] [Full Text] [Related]
7. Single-dose treatment for paucibacillary leprosy; field implications. Revankar CR; Pai VV; Samy MS; Ganapati R Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415 [No Abstract] [Full Text] [Related]
8. Chemotherapy of leprosy. Biswas SK; J Indian Med Assoc; 2004 Dec; 102(12):695-6, 698. PubMed ID: 15871354 [TBL] [Abstract][Full Text] [Related]
10. Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study. Martelli CM; Stefani MM; Gomes MK; Rebello PF; Peninni S; Narahashi K; Maroclo AL; Costa MB; Silva SA; Sacchetim SC; Nery JA; Salles AM; Gillis TP; Krahenbuhl JL; Andrade AL Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):247-57. PubMed ID: 11221086 [TBL] [Abstract][Full Text] [Related]
11. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions. Deshmukh AR; Dhurat RS; Jerajani HR Indian J Lepr; 2003; 75(3):209-17. PubMed ID: 15267190 [TBL] [Abstract][Full Text] [Related]
12. A comparative trial of single dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions. 2-3 Lesion Multicentre Trial Group Indian J Lepr; 2001; 73(2):131-43. PubMed ID: 11579649 [TBL] [Abstract][Full Text] [Related]
13. The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy. Balagon MF; Cellona RV; Abalos RM; Gelber RH; Saunderson PR Lepr Rev; 2010 Mar; 81(1):27-33. PubMed ID: 20496567 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial. Manickam P; Nagaraju B; Selvaraj V; Balasubramanyam S; Mahalingam VN; Mehendale SM; Pannikar VK; Gupte MD; Indian J Lepr; 2012; 84(3):195-207. PubMed ID: 23484334 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of single dose multidrug therapy for the treatment of single-lesion paucibacillary leprosy. Single-lesion Multicentre Trial Group. Indian J Lepr; 1997; 69(2):121-9. PubMed ID: 9290963 [TBL] [Abstract][Full Text] [Related]
16. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil. Cunha Mda G; Virmond M; Schettini AP; Cruz RC; Ura S; Ghuidella C; Viana Fdos R; Avelleira JC; Campos AA; Filho B Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027 [TBL] [Abstract][Full Text] [Related]
17. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens. Emmanuel M; Gupte MD Indian J Lepr; 2005; 77(1):19-25. PubMed ID: 16173416 [TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India. Kumar A; Girdhar A; Girdhar BK Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850 [TBL] [Abstract][Full Text] [Related]
19. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity. Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]